Crossmark

Characterization of AmpC β-lactamase mutations of extensively drug-resistant Pseudomonas aeruginosa isolates that develop resistance to ceftolozane/tazobactam during therapy

Crossref DOI link: https://doi.org/10.1016/j.eimc.2020.01.017

Published Print: 2020-12

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Fernández-Esgueva, Marta

López-Calleja, Ana Isabel

Mulet, Xavier

Fraile-Ribot, Pablo A.

Cabot, Gabriel

Huarte, Rafael

Rezusta, Antonio

Oliver, Antonio
Funding

Funding for this research was provided by:

Pfizer

Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica
License Information

Text and Data Mining valid from 2020-12-01
More Information

This article is maintained by: Elsevier

Article Title: Characterization of AmpC β-lactamase mutations of extensively drug-resistant Pseudomonas aeruginosa isolates that develop resistance to ceftolozane/tazobactam during therapy

Journal Title: Enfermedades Infecciosas y Microbiología Clínica

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.eimc.2020.01.017

Content Type: article

Copyright: © 2020 Elsevier España, S.L.U. and Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. All rights reserved.

Document is current

Any future updates will be listed below